Oct 2017 19 Philogen announces the authorisation of a clinical trial with PHC-102 for the imaging of renal cell carcinoma.
Oct 2017 12 Philogen announces authorization from FDA of a pivotal registration trial in USA for the treatment of resectable melanoma
